Jianai Ji
China Pharmaceutical University(CN)Jiangsu Vocational College of Medicine(CN)State Key Laboratory of Natural Medicine
Publications by Year
Research Areas
Genomics, phytochemicals, and oxidative stress, Glutathione Transferases and Polymorphisms, Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, CAR-T cell therapy research
Most-Cited Works
- → The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update(2016)766 cited
- → Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway(2018)281 cited
- → An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis(2016)113 cited
- → Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope(2022)39 cited
- → Polar Recognition Group Study of Keap1-Nrf2 Protein–Protein Interaction Inhibitors(2016)34 cited
- → ARE-PROTACs Enable Co-degradation of an Nrf2–MafG Heterodimer(2023)33 cited
- → Bivalent inhibitors of the BTB E3 ligase KEAP1 enable instant NRF2 activation to suppress acute inflammatory response(2023)17 cited
- → Discovery of a NCOA4 Degrader for Labile Iron-Dependent Ferroptosis Inhibition(2024)12 cited